Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery-Reference-Cited by-同舟云学术

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery

Published:2006-04 Issue:4 Volume:43 Page:742-751.e1
ISSN:0741-5214
Container-title:Journal of Vascular Surgery
language:en
Short-container-title:Journal of Vascular Surgery

Author:

Conte Michael S.,Bandyk Dennis F.,Clowes Alexander W.,Moneta Gregory L.,Seely Lynn,Lorenz Todd J.,Namini Hamid,Hamdan Allen D.,Roddy Sean P.,Belkin Michael,Berceli Scott A.,DeMasi Richard J.,Samson Russell H.,Berman Scott S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference18 articles.

1. Stranger in a strange land;Cox;Prog Cardiovasc Dis,1991

2. Genetic interventions for vein bypass graft disease;Conte;J Vasc Surg,2002

3. Present status of reversed vein bypass grafting;Taylor;J Vasc Surg,1990

4. Impact of increasing comorbidity on infrainguinal reconstruction;Conte;Ann Surg,2001

5. Infrainguinal bypass;Mills,2005

Cited by 570 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower Extremity Bypass for Occlusive Disease: A Brief History;Annals of Vascular Surgery;2024-10

2. Alternative Conduits for Lower Extremity Bypass;Annals of Vascular Surgery;2024-10

3. Advancements in Omics and Breakthrough Gene Therapies: A Glimpse into the Future of Peripheral Artery Disease;Annals of Vascular Surgery;2024-10

4. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications;Molecular Therapy - Methods & Clinical Development;2024-09

5. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial;Journal of Vascular Surgery;2024-09